Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00001702 |
Recruitment Status
:
Completed
First Posted
: November 4, 1999
Last Update Posted
: July 2, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Blastomycosis |
Study Type : | Observational |
Enrollment : | 400 participants |
Official Title: | Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection |
Study Start Date : | July 29, 1998 |
Actual Primary Completion Date : | June 6, 2007 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Patients in the database have been confirmed with a diagnosis of Blastomycosis dermatitides infection by a combination of isolation of the yeast form in a diagnostic microbiology laboratory and/or an elevated cryptococcal antigen titer (which is commercially available).
Only patients diagnosed and treated in the United States and Canada will be included in this analysis.
Only patients who are not co-infected with HIV will be included in the study.
Patient samples will be collected and clinical data will be evaluated only after signed consent has been obtained.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001702
United States, Alabama | |
University of Alabama | |
Birmingham, Alabama, United States | |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | |
Bethesda, Maryland, United States, 20892 |
Publications:
ClinicalTrials.gov Identifier: | NCT00001702 History of Changes |
Other Study ID Numbers: |
980138 98-C-0138 |
First Posted: | November 4, 1999 Key Record Dates |
Last Update Posted: | July 2, 2017 |
Last Verified: | October 6, 2009 |
Keywords provided by National Institutes of Health Clinical Center (CC):
Genetic Variant Alleles Risk Factor Cancer Transplantation |
Additional relevant MeSH terms:
Infection Blastomycosis Dermatomycoses Skin Diseases, Infectious Mycoses |
Lung Diseases, Fungal Lung Diseases Respiratory Tract Diseases Respiratory Tract Infections Skin Diseases |